In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis
- 30 April 2004
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 111 (1) , 61-68
- https://doi.org/10.1016/j.clim.2003.12.006
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (13670818)
This publication has 36 references indexed in Scilit:
- CONTRIBUTING FACTORS TO THE PATHOBIOLOGYClinics in Chest Medicine, 2000
- Mutations of the IL-12 Receptor β2 Chain Gene in Atopic SubjectsBiochemical and Biophysical Research Communications, 1999
- Interleukin-18 Enhances Antigen-induced Eosinophil Recruitment into the Mouse AirwaysAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Reduced interferon-γ but normal IL-4 and IL-5 release by peripheral blood mononuclear cells from Xhosa children with atopic asthmaJournal of Allergy and Clinical Immunology, 1997
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Decreased frequency of interferon-γ– and interleukin-2–producing cells in patients with atopic diseases measured at the single cell levelJournal of Allergy and Clinical Immunology, 1995
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Interleukin-2 and Soluble lnterleukin-2 Receptor in Bronchoalveolar Lavage Fluid From Patients With Bronchial AsthmaChest, 1994
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993
- Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseasesClinical and Experimental Immunology, 1991